Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
The company has raised US$4.5 million in funding for its AI operating system
Lack of technology transfer stands out as a formidable barrier
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
Subscribe To Our Newsletter & Stay Updated
